Health Impact Assessment Use in Australia -Myassignmenthelp.Com

Question: Discuss About The Health Impact Assessment Use In Australia? Answer: Introducation E-cigarettes are increasingly popular among cigarette smokers who wish to reduce their consumption of tobacco. Impact Assessments have been conducted to establish the implications of e-cigarette smoking; whether it increases or decreases the smoking cessation. This paper reports the findings of screening and scoping process of e-cigarettes by the Australian government. Electronic cigarettes (e-cigarettes) also known as personal vaporisers (PVs) have elicited concerns from relevant stakeholders the world over on their applicability in inducing smoking cessation and reduction. Fraser et al. (2015) assert that the use of PVs has increased healthcare in Australia despite the legal barriers to the sale, possession and use of nicotine for non-therapeutic purposes. PVs are expected to reduce the harm of tobacco smoking. As such it has been proposed that the government should make exceptions from nicotine concentrations that are below 3.6 percent for self-administration through the E-cigarette system (Therapeutic Goods Administration (TGA), 2018). There is international evidence that e-cigarettes help smokers to reduce and quit tobacco smoking. E-cigarettes address both the pleasure of nicotine use and the habit of smoking. However, users must be cautioned through labelling and correct displaying of relevant warnings and consumer information. The health impact assessment of e-cigarettes should include both the economic and legal implications; however, the main aim is to improve peoples health and cost of health systems (TGA, 2018). In conclusion, e-cigarettes are a harm reduction strategy for tobacco smokers. Therefore, Australia should use the available resources to develop regulations on the e-cigarettes. References Fraser, D., Weier, M., Keane, H. and Gartner, C. (2015). Vapers perspectives on management cigarette regulation in Australia. International Journal of Drug Policy, 26(6), pp.589-594. Therapeutic Goods Administration (TGA). (2018). 2.1 Nicotine. [operations] Available at: https://www.tga.gov.au/book-page/21-nicotine-0 [Accessed 1 Feb. 2018].